Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.
D000818:Animals; D000906:Antibodies / Q000494:pharmacology*; D000936:Antigen-Antibody Complex / Q000032:analysis; D023201:CD40 Ligand / Q000276:immunology*; D018925:Chemokines / Q000235:genetics; D016207:Cytokines / Q000235:genetics; D005260:Female; D015870:Gene Expression / Q000276:immunology; D007167:Immunotherapy / Q000379:methods; D007668:Kidney / Q000737:chemistry / Q000276:immunology / Q000473:pathology; D008181:Lupus Nephritis / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008814:Mice, Inbred NZB; D012333:RNA, Messenger / Q000032:analysis; D013997:Time Factors
D000906:Antibodies; D000936:Antigen-Antibody Complex; D018925:Chemokines; D016207:Cytokines; D012333:RNA, Messenger; D023201:CD40 Ligand